The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is a condition with increasing incidence, leading to a health care problem of epidemic proportions for which no curative treatments exist. Consequently, an urge exists to better understand the pathophysiology of HFpEF. Accumulating evidence sugg...

Full description

Bibliographic Details
Main Authors:	Jerremy Weerts, Sanne G. J. Mourmans, Arantxa Barandiarán Aizpurua, Blanche L. M. Schroen, Christian Knackstedt, Etto Eringa, Alfons J. H. M. Houben, Vanessa P. M. van Empel
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Biomolecules
Subjects:	heart failure with preserved ejection fraction microcirculation microvascular dysfunction endothelial dysfunction
Online Access:	https://www.mdpi.com/2218-273X/12/2/278

Similar Items

Retinal Vascular Changes in Heart Failure with Preserved Ejection Fraction Using <i>Optical Coherence Tomography Angiography</i>
by: Jerremy Weerts, et al.
Published: (2024-03-01)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
by: Domenico D’Amario, et al.
Published: (2019-11-01)

Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction
by: Ariane A. Sickinghe, et al.
Published: (2019-07-01)

Findings suggestive of coronary microvascular dysfunction in cats with myocardial ischemia
by: Guillermo Belerenian, et al.
Published: (2021-09-01)

Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort
by: Elisa Dal Canto, et al.
Published: (2023-09-01)

Coronary Microvascular Injury in Reperfused Acute Myocardial Infarction: A View From an Integrative Perspective
by: Murat Sezer, et al.
Published: (2018-11-01)

Invasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease
by: Guus A. de Waard, et al.
Published: (2016-12-01)

Coronary microvascular dysfunction: A review of recent progress and clinical implications
by: Rajan Rehan, et al.
Published: (2023-01-01)

Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients
by: Camilla Hage, et al.
Published: (2020-08-01)

Microvascular Dysfunction and Whole‐Brain White Matter Connectivity: The Maastricht Study
by: Magdalena Beran, et al.
Published: (2024-02-01)

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
by: Sandy Joung, et al.
Published: (2019-05-01)

Microvascular angina – an abstruse path to diagnose and to treat – a review of literature
by: Urszula Matuszewska, et al.
Published: (2024-01-01)

Penile microvascular endothelial function in hypertensive patients: effects of acute type 5 phosphodiesterase inhibition
by: V. Verri, et al.
Published: (2018-01-01)

Coronary Microvascular Dysfunction: Features and Prognostic Value
by: Kristina Kopeva, et al.
Published: (2023-04-01)

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
by: Yan Lin, et al.
Published: (2022-08-01)

Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2021-11-01)

Coronary microvascular dysfunction in heart failure patients
by: Takumi Toya, et al.
Published: (2023-06-01)

Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
by: Sadi Loai, et al.
Published: (2021-07-01)

Randomized, crossover, controlled trial on the modulation of cardiac coronary sinus hemodynamics to develop a new treatment for microvascular disease: Protocol of the MACCUS trial
by: Helen Ullrich, et al.
Published: (2023-02-01)

International prospective cohort study of microvascular angina – Rationale and design
by: Akira Suda, et al.
Published: (2020-12-01)

Treatment of essential hypertension does not normalize capillary rarefaction
by: Guilherme Loures de Araújo Penna, et al.
Published: (2008-01-01)

Non-pharmacological Treatment of Refractory Angina and Microvascular Angina
by: Kudrat Rakhimov, et al.
Published: (2020-08-01)

Coronary Microvascular Dysfunction
by: Federico Vancheri, et al.
Published: (2020-09-01)

Advances and Challenges in Biomarkers Use for Coronary Microvascular Dysfunction: From Bench to Clinical Practice
by: Erica Rocco, et al.
Published: (2022-04-01)

Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation
by: Maarten M. Brandt, et al.
Published: (2021-12-01)

Microcirculation in Patients with Takotsubo Syndrome—The Prospective CIRCUS-TTS Study
by: Christian Möller, et al.
Published: (2021-05-01)

Association of mild kidney dysfunction with diastolic dysfunction and heart failure with preserved ejection fraction
by: Robin W. M. Vernooij, et al.
Published: (2024-02-01)

Evaluation of microvascular endothelial function in patients with infective endocarditis using laser speckle contrast imaging and skin video-capillaroscopy: research proposal of a case control prospective study
by: Amanda Barcelos, et al.
Published: (2017-07-01)

Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent Differences
by: Sadi Loai, et al.
Published: (2022-05-01)

Cardiac syndrome X: An important cause of microvascular angina
by: Batur Gönenç Kanar, et al.
Published: (2018-09-01)

Microvascular Dysfunction in Takotsubo Cardiomyopathy
by: Shreyas Gowdar, et al.
Published: (2016-01-01)

Assessing the Coronary Microcirculation in Patients After Primary Percutaneous Coronary Intervention
by: Andy S. C. Yong, et al.
Published: (2018-08-01)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
by: Mikael Erhardsson, et al.
Published: (2023-12-01)

Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
by: Utkarsh Dutta, et al.
Published: (2023-01-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018-01-01)

Coronary Microvascular Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Artery Disease Is Associated With Elevated Serum Homocysteine Levels
by: Ali Ahmad, et al.
Published: (2020-10-01)

Incremental Prognostic Impact of Peripheral Microvascular Endothelial Dysfunction on the Development of Ischemic Stroke
by: Takumi Toya, et al.
Published: (2020-05-01)

Coronary Microvascular Dysfunction: Epidemiology, Clinical Presentation, Diagnosis and Treatment
by: E. L. Trisvetova
Published: (2023-05-01)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
by: Sharon Remmelzwaal, et al.
Published: (2020-10-01)